Prof. Martin J. Blaser - Speaker at Microbiota events
Microbiotaevents chevron Speakers chevron Martin J. Blaser

Prof. Martin J. Blaser

Director of the Center for Advanced Biotechnology and Medicine and Professor of medicine in universities (New Jersey, USA)

Prof. Martin J. Blaser holds the Henry Rutgers Chair of the Human Microbiome at Rutgers University (NJ, USA), where he also serves as Professor of Medicine and Pathology & Laboratory Medicine, and as Director of the Center for Advanced Biotechnology and Medicine. Prof. Blaser is also Professor of Epidemiology and Biostatistics at the School of Public Health (Rutgers University) and Chair of the Presidential Advisory Council for Combating Antibiotic Resistant Bacteria (PACCARB).

  • Chair of the Presidential Advisory Council for Combating Antibiotic Resistant Bacteria (PACCARB)
  • Henry Rutgers Chair of the Human Microbiome
  • Member, National Academy of Medicine
  • Member, American Academy of Arts & Sciences 
  • Past Chair of the National Cancer Institute Board of Scientific Counselors
  • Past Member of the Board of Governors American Academy of Microbiology
  • Past President of the Infectious Diseases Society of America

Prof. Martin J. Blaser holds the Henry Rutgers Chair of the Human Microbiome at Rutgers University (NJ, USA), where he also serves as Professor of Medicine and Pathology & Laboratory Medicine, and as Director of the Center for Advanced Biotechnology and Medicine. Prof. Blaser is also Professor of Epidemiology and Biostatistics at the School of Public Health (Rutgers University) and Chair of the Presidential Advisory Council for Combating Antibiotic Resistant Bacteria (PACCARB).

  • Chair of the Presidential Advisory Council for Combating Antibiotic Resistant Bacteria (PACCARB)
  • Henry Rutgers Chair of the Human Microbiome
  • Member, National Academy of Medicine
  • Member, American Academy of Arts & Sciences 
  • Past Chair of the National Cancer Institute Board of Scientific Counselors
  • Past Member of the Board of Governors American Academy of Microbiology
  • Past President of the Infectious Diseases Society of America
Why you should listen

Prof. Martin J. Blaser is a physician and a microbiologist. He graduated from New York University School of Medicine in 1973 and also holds a Bachelor of Arts (B.A) in Economics from the University of Pennsylvania (1969).

 

Prof. Blaser has been studying the relationships we have with our persistently colonizing bacteria. His work over 30 years focused on Campylobacter species and Helicobacter pylori, which also are model systems for understanding the interactions of residential bacteria with their hosts. Over the last 20 years, he has also been actively studying the relationship of the human microbiota with health and important diseases including asthma, obesity, diabetes, and cancer.

 

He has served as the advisor to many students, post-doctoral fellows, and junior faculty. He has been actively involved in national scientific and professional organizations.  He served as President of the Infectious Diseases Society of America, Chair of the Board of Scientific Counselors of the National Cancer Institute, and Chair of the Advisory Board for Clinical Research of the National Institutes of Health. He currently serves as Chair of the Presidential Advisory Council for Combating Antibiotic Resistant Bacteria (PACCARB). He holds 28 U.S. patents and has authored over 600 original articles. He wrote « Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues », a book targeted to general audiences, now translated into 20 languages and named as the «Best popular medicine books of 2014» by The Guardian.

 

During his career, Prof. Blaser has received many honors (National Academy of Medicine, American Academy of Arts and Sciences) and Awards (Oswald Avery Award, Alexander Fleming Award, Robert Koch Gold Medal). He has been recently elected one the 100 Most Influential People in the World (2015) as « an incredibly important voice on the consequences of our rampant overuse of antibiotics ».

Key Studies

Gilbert J-A. et al

Current understanding of the human microbiome.  

Nat Med. 2018 Apr 10;24(4):392-400.  

https://pubmed.ncbi.nlm.nih.gov/29634682/  

Blaser M-J. 

The Past and Future Biology of the Human Microbiome in an Age of Extinctions.  

Cell. 2018 Mar 8;172(6):1173-1177.  

https://pubmed.ncbi.nlm.nih.gov/29522739/  

Schulfer A-F. et al

Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice 

Nat Microbiol. 2018 Feb;3(2):234-242.  

https://pubmed.ncbi.nlm.nih.gov/29180726/  

Cox L-M. et al

Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences 

Cell. 2014 Aug 14;158(4):705-721. 

https://pubmed.ncbi.nlm.nih.gov/25126780/  

Cho I. et al

Antibiotics in early life alter the murine colonic microbiome and adiposity  

Nature. 2012 Aug 30;488(7413):621-6.  

https://pubmed.ncbi.nlm.nih.gov/22914093/  

Cho I., Blaser M-J. 

The human microbiome: at the interface of health and disease  

Nat Rev Genet. 2012 Mar 13;13(4):260-70.  

https://pubmed.ncbi.nlm.nih.gov/22411464/  

 

Prof. Martin J. Blaser’s Microbiota Events

Saturday, 21st August 2021
12:30am - 1:30pm (CEST)

How the gut microbiome in particular can influence host health in the context of the COVID-19 pandemic.